An Israel-based medical device maker has picked Atlanta for its North American headquarters. The company makes products that could help a growing number of people diagnosed with a sleep disorder.
Itamar Medical Inc. (TASE: ITMR) has developed the WatchPAT, a Food and Drug Administration (FDA)-approved device for the diagnosis of sleep apnea in the home environment. Sleep apnea is a medical condition that affects one in four people in the United States and is typically associated with cardiovascular disease.
According to this week’s Atlanta Business Chronicle, Itamar’s North American headquarters was in the Boston area. It was attracted to Atlanta because of the region’s medical sales and product management workforce, and proximity to a globally connected airport.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
